Brenton K. Ahrens - Director at Iterum Therapeutics plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ITRM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Brenton K. Ahrens since 7/7/2023

Holdings reported by Brenton K. Ahrens for Iterum Therapeutics plc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 29,125 $23.6 K $0.81 Dec 23, 2022 Direct Ordinary Shares
Ordinary Shares 410 $574 $1.40 Sep 16, 2022 Direct
Share Option (Right to Buy) 647,059 Jun 15, 2022 Direct Ordinary Shares
Ordinary Shares 0 $1.40 Sep 20, 2022 Indirect

Transactions reported by Brenton K. Ahrens for Iterum Therapeutics plc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership